Himalaya's Logo
  Search
  Health Help
 
   
 
Direct from Himalaya online.
 
 
Click to select your location.
 
   
Medicinal Range   Animal Health   Personal Care
   
Abana
Bonnisan
Bonnispaz
Clarina
Confido
Cystone
Diabecon
Diakof
Diarex
Evecare
Gasex
Geriforte
Herbolax
Himcocid
Himcospaz
Himplasia
Koflet
Liv.52
Lukol
Menosan
Mentat
Ophthacare
Picrolax
Pilex
PureHands
Purim
Renalka
Reosto
Rumalaya
Rumalaya forte
Rumalaya gel
Rumalaya liniment
Septilin
Serpina
Speman
Styplon
Talekt
Tentex forte
Tentex Royal
V-Gel
Anxocare
Appetonic Vet
Diarex Vet
Digyton
Erina
Galactin Vet
Geriforte Vet
Himfertin Vet
Inflamin Vet
Immunol
Liv.52 Protec (Poultry)
Liv.52 Vet
Scavon
Speman Vet
Speman forte Vet
Tentex forte Vet (Poultry)
Acne-n-Pimple Cream
Anti-dandruff Hair Cream
Anti-dandruff Hair Oil
Anti-dandruff Shampoo
Anti-wrinkle Cream
Ayurslim Capsule
Baby Cream
Baby Lotion
Baby Powder
Cold Balm
Dental Cream
Diaper Rash Cream
Fairness Cream
Hair Loss Cream
Muscle & Joint Rub
Nourishing Baby Oil
Pain Balm
Sunscreen Lotion
Under Eye Cream
To view the clinical papers, your system needs the free Adobe Acrobat Reader, version 4 or later.
Click here to download.
 
Total no. of papers:11 - Clinical Papers:10, Experimental Papers:1  
(Research papers based on Indications)  
Highlighted journal names are international publications  
   
*PR-2000/Prostane is marketed as Himplasia  
Benign prostatic hyperplasia  
  1. Evaluation of clinical efficacy and safety of Himplasia in BPH: A prospective, randomized, placebo-controlled, double blind, phase III clinical trial
    Dr. Pranjal R. Modi1, DNB (Urology) and Dr. S.A. Kolhapure2*, MD. 1Department of Urology and Transplantation Surgery, Institute of Kidney Diseases & Research Centre, BJ Medical College & Civil Hospital, Ahmedabad, India, 2Senior Medical Advisor, R&D Center, The Himalaya Drug Company, Bangalore, India, Medicine Update 2004: 12(6), 33.

  2. Evaluation of the efficacy and safety of Himplasia in BPH: A randomised, double-blind, placebo-controlled, phase III clinical trial
    Dr. Saswata Chakraborty, M.S.1, Dr. Dilip Karamakar, M.S., M.Ch.2, Dr. S.A. Kolhapure, M.D.,3* 1Research Assistant, 2Professor & Head, Department of Urology, Calcutta National Medical College & Hospital, Kolkata, India. 3Senior Medical Advisor, R&D Center, The Himalaya Drug Company, Bangalore, India, Medicine Update (2004): 12(4), 39.

  3. Evaluating the Efficacy and Safety of Himplasia (PC-27) in the Medical Management of Benign Prostatic Hyperplasia
    Ketan Shukla, Consultant Urologist & Transplant Surgeon, Sterling Hospital, Behind Drive-in Cinema, Ahmedabad, India, and Kolhapure, S.A., R&D Center, The Himalaya Drug Company, Bangalore, Karnataka, India, Indian Journal of Clinical Practice (2004): April issue.

  4. Clinical evaluation of Himplasia in benign prostatic hyperplasia: An open clinical trial
    Manoranjan Sahu, Ramesh Bhat, P., Department of Shalya Shalakya, Sir Sundarlal Hospital, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India, and Kala Suhas Kulkarni, R&D Center, The Himalaya Drug Company, Bangalore, India, Medicine Update (2003): (11), 1, 75.

  5. Role of herbal drugs in the management of benign prostatic hyperplasia: Clinical trial to evaluate the efficacy and safety of Himplasia
    Arora, R.P., Rajiba L. Nayak, Vineet Malhotra, Mohanty, N.K., Department of Urology, Safdarjang Hospital, New Delhi, India, and Kala Suhas Kulkarni, R&D Center, The Himalaya Drug Company, Bangalore, India, Medicine Update (2003): 11 (2), 55.

  6. Double-blind placebo-controlled study of PR-2000 in the management of benign prostatic hyperplasia
    Garg, S.K., M.S., D.N.B. (Surgery), M.Ch., D.N.B. (Urology) Bombay, Urologist and Transplant Surgeon, Garg Urological Clinic, B-51, Brij Enclave Colony, Varanasi-221 005, Uttar Pradesh, India, and
    Kala Suhas Kulkarni*, M.D., Medical Advisor, R&D Center, The Himalaya Drug Company, Makali, Bangalore, India, The Antiseptic (2002): (99), 1, 8.


  7. Use of PR-2000, a herbal formulation in the medical management of benign prostatic hyperplasia
    Shukla, G.N., Medical Superintendent & Professor of Surgery, C.U. Shah Medical College, Dudhrej Road, Surendranagar-363 001. Gujarat, India, and Mahender Nayak, Senior Executive - R&D Center, The Himalaya Drug Company, Bangalore, India, Indian Journal of Clinical Practice (2002): (13), 2, 53.

  8. A study of Prostane in the treatment of benign prostatic hyperplasia
    Lokesh Upadhyay and Tripathi, K., Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India, Phytotherapy Research (2001): (15), 411.


  9. Efficacy and safety of a herbal preparation PR-2000 in the treatment of symptomatic benign prostatic hyperplasia
    Sahu, M., Reader and Head, Department of Shalaya Shalakya, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India,
    and Vijay Kumar, V., M.B.B.S., Clinical Research Associate, R&D Center, The Himalaya Drug Company, Makali, Bangalore, India, JAMA India - The Physicians' Update (2001): 4 (12), 43.

  10. Efficacy and safety of 'Prostane' in the management of symptomatic benign prostatic hyperplasia: A clinical evaluation
    Singh, K.M., M.S., F.I.C.S., F.A.C.S., M.N.M.S., Head, Department of Urology, King George's Medical College, Lucknow, India, JAMA India - The Physicians' Update (2001): (4), 11, 43.

  11. Protective effect of Prostane* in experimental prostatic hyperplasia in rats
    Mitra, S.K., Sundaram, R., Mohan, A.R., Gopumadhavan, S., Venkataranganna, M.V., Venkatesha Udupa, Seshadri, S.J. and Anturlikar, S.D., The Himalaya Drug Company, Bangalore, Karnataka, Asian Journal of Andrology (1999): (1), 4, 175.
     
  FAQs   |   Glossary   |   Sitemap   |   Privacy Policy   |   Terms of Use  
  Copyright © 2002 The Himalaya Drug Company.